Stroke Diagnostics Market Size, Share & Trends Analysis Report By Product Type (Magnetic Resonance Imaging (MRI), Computed Tomography Scan (CT Scan), Carotid Ultrasound, Nuclear Imaging, Cerebral Angiography, Others), By Stroke Type (Ischemic Stroke, Hemorrhagic Stroke, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Stroke Diagnostics Market Size

The global stroke diagnostics market size was valued at USD 3.31 billion in 2025 and is projected to grow from USD 3.55 billion in 2026 to USD 6.27 billion by 2034, registering a CAGR of 7.35% during the forecast period from 2026 to 2034. North America dominated the stroke diagnostics market with a market share of 38.2% in 2025.

Stroke diagnostics refers to the methods and tools used to identify and evaluate strokes, enabling timely and effective treatment. The market for stroke diagnostics is witnessing rapid growth, driven by the increasing incidence of brain attacks across various age groups, the integration of artificial intelligence (AI) in diagnostic systems, and the rising demand for precise diagnostic methods.

• For instance, according to the McLaren Health Organization, in 2024, approximately 15 million people globally experience a stroke each year, with 60% of cases occurring in individuals under the age of 70. This alarming statistic highlights the growing need for advanced diagnostic tools to improve patient outcomes.

Moreover, the availability of diverse diagnostic methods, including MRI, CT scans, ultrasound, and nuclear imaging, creates significant opportunities for market players to develop and launch a wide range of innovative products. These advancements are not only enhancing diagnostic accuracy but also accelerating the growth of the global market.

Product Type Insights

The computed tomography scan (CT Scan) segment dominates the market with the largest market revenue, accounting for the largest market revenue. CT scans are highly effective in diagnosing brain attacks due to their ability to produce detailed images of the brain.

This technique can detect bleeding, ischemic strokes, tumors, and other conditions, offering quick results. The speed of CT scans is a key advantage, as they typically take only 8-10 minutes to complete, compared to longer MRI procedures.

• Advancements in CT technology, such as the FDA clearance for NeuroLogica Corp's ultra-high-resolution Photon Counting Detector (PCD) in July 2024, further enhance diagnostic capabilities, solidifying the segment’s market leadership.

Request Customizationto receive a tailored report.

Stroke Type Insights

The Ischemic Stroke segment leads the market in revenue, primarily due to its higher prevalence and mortality rates compared to other types of strokes. Ischemic stroke, accounting for about 85% of all stroke cases, requires early and accurate detection for timely treatment. The increased awareness surrounding ischemic stroke drives demand for diagnostic technologies to facilitate early intervention and reduce the risk of severe outcomes.

• According to recent statistics, there were 69.94 million cases of ischemic stroke in 2021, underscoring its significant impact and driving continued demand for advanced diagnostic solutions.

End User Insights

The Diagnostic Laboratories segment holds the largest revenue share, owing to its critical role in brain attack diagnosis. Diagnostic laboratories are equipped with a range of technologies and diagnostic methods, including CT scans, MRIs, and ultrasounds, enabling them to provide accurate stroke diagnoses.

As stroke diagnostics require specialized equipment and expertise, diagnostic laboratories are key players in the process, contributing to their dominant position in the market. Their ability to offer comprehensive and timely diagnostics enhances their market growth, meeting the increasing demand for early brain attack detection and treatment.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America dominates the global market with 40.23% market share, driven by a combination of factors, including a well-established healthcare infrastructure, substantial investments in the latest diagnostic equipment, and the high prevalence of stroke cases. The presence of major industry players such as GE Healthcare, Siemens Healthcare, Fujifilm Corporation, Canon Medical Systems, Alpinion Medical Systems, Analogic Corporation, and IMRIS Inc. further boosts the region's market growth. These companies' continuous innovation and product advancements strengthen North America's leadership position.

• US. – The U.S. leads the market due to its robust healthcare system and the presence of major players like GE Healthcare, Siemens Healthcare, Fujifilm, and Canon Medical Systems. The country’s advanced diagnostic equipment and partnerships, such as the one between Philips and Medtronic in October 2024, further strengthen its position as a market leader.
• Canada – Canada’s aging population, which reached 18.9% in 2023, plays a significant role in driving the market. The increasing number of elderly individuals presents a higher risk of stroke, amplifying the need for diagnostic solutions. Canada’s advanced healthcare infrastructure also contributes to the growth of the market.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific Stroke Diagnostics Market Trends

The Asia-Pacific region is expected to experience the fastest growth. This surge is driven by factors such as the rising incidence of stroke, growing public awareness about the importance of early diagnosis, and the increasing availability of advanced diagnostic methods. The expansion of healthcare facilities and the adoption of cutting-edge diagnostic technologies are also contributing to the region's rapid market growth.

• China – The growth of stroke diagnostics in China is driven by the government's focus on healthcare infrastructure, technological advancements, and the development of skilled professionals. These factors, along with rising brain attack incidence, contribute to China’s rapidly expanding market, improving diagnostic capabilities and access across the country.
• India– The rising incidence and prevalence of stroke in India, with an incidence rate of 108-172 per 100,000 people, significantly drive the demand for stroke diagnostic devices. As the country faces increasing stroke cases, the need for timely and accurate diagnosis rises, fueling the growth of the stroke diagnostics market.
• Australia - Australia’s Stroke Foundation plays a crucial role in advancing stroke diagnostics through funding research, new technologies, and frontline support services. The foundation’s focus on R&D and investment in innovative solutions drives the market for advanced brain attack diagnostic technologies, supporting the nation’s overall healthcare infrastructure.

Europe Stroke Diagnostics Market Trends

• Germany– Germany, home to Siemens Healthineers, a key player in brain attack diagnostics, is witnessing strong market growth. Siemens is involved in a €28.22 million project aimed at improving stroke care in Europe, collaborating with hospitals across Germany, Belgium, Italy, and other countries. Such initiatives drive innovation and expand the market in Germany.
• UK – The UK’s National Health Service (NHS) has launched the National Stroke Programme in collaboration with the Stroke Association. This initiative, developed with clinical experts, aims to enhance stroke care from diagnosis to treatment. The program’s comprehensive approach is pivotal in advancing brain attack diagnostics and management across the UK.
• France – Government initiatives are vital for boosting the regional market in France. For example, in May 2024, the French government allocated $4.41 million for innovative hemorrhagic stroke treatments. Such funding supports the development of new stroke management technologies, further enhancing diagnostic capabilities within the country.

Company Market Share

Key players in the stroke diagnostics market, such as GE Healthcare, Siemens Healthineers, Philips, and Fujifilm Corporation, are pursuing strategic collaborations, acquisitions, and partnerships to enhance their product offerings and broaden their market reach. These alliances allow companies to integrate advanced technologies like artificial intelligence, improve diagnostic accuracy, and expand into new regions.

Esaote Ltd: An Emerging Provider in the Global Stroke Diagnostics Market

Esaote is an emerging player in the global market, known for its commitment to research and development in imaging systems. The company continuously focuses on enhancing its product offerings by incorporating new technologies such as advanced MRI and ultrasound systems. These modifications are aimed at improving diagnostic accuracy and patient outcomes.

Esaote's innovation-driven approach helps meet the growing demand for more efficient and reliable brain attack diagnostic tools, positioning it as a key player in the evolving market landscape.

List of Key and Emerging Players in Stroke Diagnostics Market